Showing results (1-10 of 163) with videos related to
Sort By:
Pageof 17
Clinical Calcium|July 28, 2018
[Fragility Fractures in Hemodialysis Patients. Uremic toxins-related abnormal bone metabolism.]Suguru YamamotoClinical and Experimental Nephrology|June 6, 2018
Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β2-microglobulin-related amyloidosis and indoxyl sulfate-induced atherosclerosis-Oshima Award Address 2016Suguru YamamotoBiochimica Et Biophysica Acta|October 18, 2005
Historical background and clinical treatment of dialysis-related amyloidosisSuguru Yamamoto, Fumitake GejyoCurrent Opinion in Nephrology and Hypertension|April 18, 2009
Mechanisms for increased cardiovascular disease in chronic kidney dysfunctionSuguru Yamamoto, Valentina KonClinical and Experimental Nephrology|September 11, 2013
Chronic kidney disease induced dysfunction of high density lipoproteinSuguru Yamamoto, Valentina KonClinical Calcium|May 2, 2007
[Mechanism of beta(2)-microglobulin-related amyloid fibril formation in CKD]Suguru Yamamoto, Junichiro James KazamaTherapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 18, 2021
Magnesium intake by enteral formulation affects serum magnesium concentration in patients undergoing hemodialysisKou Kitabayashi, Suguru Yamamoto, Ichiei NaritaPeritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 6, 2007
High peritoneal clearance of small molecules did not provide low serum beta2-microglobulin concentrations in peritoneal dialysis patientsSuguru Yamamoto, Akio Kasai, Hisaki ShimadaClinica Chimica Acta; International Journal of Clinical Chemistry|April 19, 2016
The macrophage and its related cholesterol efflux as a HDL function index in atherosclerosisSuguru Yamamoto, Ichiei Narita, Kazuhiko KotaniPageof 17